tiprankstipranks
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
US Market
IKT
Inhibikase Therapeutics
RESEARCH TOOLSreports

Inhibikase Therapeutics (IKT) Balance Sheet

377 Followers

Inhibikase Therapeutics Balance Sheet

Inhibikase Therapeutics's total assets for Q4 2025 were $181.20M, an increase of 127.66% from the previous quarter. IKT total liabilities were $8.30M for the fiscal quarter, a 23.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Mar 23Mar 22
Total Assets
$ 181.20M$ 98.60M$ 14.51M$ 24.94M$ 42.47M
Total Liabilities
$ 8.30M$ 3.73M$ 3.53M$ 3.90M$ 4.05M
Total Equity Gross Minority
$ 172.90M$ 94.87M$ 10.98M$ 21.04M$ 38.42M
Other Metrics
Currency in USD

Inhibikase Therapeutics Debt to Assets